TCL Archive Guest Editorial By ACS Chief Medical Officer Otis Brawley: ACS Revises Process for Making Guidelines January 13, 2012
TCL Archive PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III November 28, 2014
TCL Archive 5-FU/Levamisole A community Success Story; Trials With Untreated Control Revised Or Dropped October 13, 1989